SEGMENT REPORTING - Revenue (Details) - USD ($) $ in Thousands |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| SEGMENT REPORTING | ||
| Employee Expenses | $ 2,421 | $ 2,091 |
| Professional Fees | 5,253 | 3,462 |
| Manufacturing | 2,131 | 1,535 |
| Insurance | 599 | 606 |
| Segment Loss | 26,442 | 19,000 |
| Clinical development | ||
| SEGMENT REPORTING | ||
| Other Segment Items | 16 | (77) |
| Segment Loss | $ 26,442 | $ 19,000 |
| Description of other segment items | For the Year Ended December 31, | For the Year Ended December 31, |
| Clinical development | General and administrative expenses | ||
| SEGMENT REPORTING | ||
| Employee Expenses | $ 2,421 | $ 2,091 |
| Professional Fees | 5,253 | 3,462 |
| Insurance | 599 | 606 |
| Clinical development | Research and development expenses | ||
| SEGMENT REPORTING | ||
| Employee Expenses | 7,966 | 6,892 |
| Clinical Trial Expenses | 5,461 | 4,330 |
| Professional Fees | 157 | 156 |
| Manufacturing | 2,131 | 1,535 |
| License Fees | $ 2,438 | $ 5 |
| X | ||||||||||
- Definition Amount of expense for clinical trial expenses. No definition available.
|
| X | ||||||||||
- Definition The expense in the period incurred with respect to protection provided by insurance entities against risks other than risks associated with production (which are allocated to cost of sales). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate costs incurred in the production of goods for sale. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Description of composition of other segment item not separately disclosed. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount of tax expense, excluding income, excise, production and property taxes, and licenses and fees not related to production. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|